5 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 4 with minor changes only.
Primary endpoint(s) modified
Also in this update: Enrollment increased: 150 → 300 participants; Trial arms changed: 1 → 2
University of OklahomaNot specified NCT06960798 Registry history of NCT06960798 on ClinicalTrials.gov (opens the registry)
Updated
Primary completion pushed from Sep 2026 to Dec 2026
University of OklahomaNot applicable NCT07238023 Registry history of NCT07238023 on ClinicalTrials.gov (opens the registry)
Updated
Primary and study completion pushed from Sep 2026 to Dec 2026
University of OklahomaNot applicable NCT02898181 Registry history of NCT02898181 on ClinicalTrials.gov (opens the registry)
Updated
Study completion pushed from Nov 2026 to Dec 31, 2026
University of OklahomaPhase 1 NCT03587038 Registry history of NCT03587038 on ClinicalTrials.gov (opens the registry)
Updated
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Enrolling by Invitation
University of OklahomaNot applicable NCT05415371 Registry history of NCT05415371 on ClinicalTrials.gov (opens the registry)
Changed
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-09 | NCT07869420 Evaluating Feasibility and Acceptability of Pain Education | Completed | |
| 2026-10-06 | NCT07861867 AKG and Brain Health in Aging | Phase 2 | Not Yet Recruiting |
| 2026-09-22 | NCT07832617 Protoacoustic Imaging For 3D Mapping | Recruiting | |
| 2026-09-22 | NCT07833566 Biopsy-site-marker in Breast Cancer | Recruiting | |
| 2026-09-18 | NCT07829185 Modified FOLFIRINOX and Pentamidine in Advanced and Metastatic Pancreatic Cancer | Phase 1 | Not Yet Recruiting |
| Early Phase 1 | 9 | |
| Phase 1 | 10 | |
| Phase 1/2 | 1 | |
| Phase 2 | 20 | |
| Phase 2/3 | 2 | |
| Phase 3 | 1 | |
| Phase 4 | 6 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT05587361 | Beta-Adrenergic Modulation of Drug Cue Reactivity | Tobacco Use Disorder | Recruiting | 2026-04-28 |
| NCT04248205 | Ketamine for Post-operative Analgesia in Hemorrhoidectomy | Hemorrhoids | Recruiting | 2026-04-01 |
| NCT05483465 | The Effect of NAD Supplementation on Brain Vascular Health in Aging | Aging | Recruiting | 2026-04-01 |
| NCT07200544 | Meloxicam in Mohs Micrographic Surgery | Postoperative Pain, Acute | Recruiting | 2025-12-15 |
| NCT06986993 | Impact of Semaglutide on Tobacco Use and Related Health Behaviors | Tobacco Use | Recruiting | 2025-08-27 |
| NCT04831398 | The Effects of Acute Melatonin Supplementation on Cardiovascular Responses to Sympathetic… | Healthy | Active, Not Recruiting | 2026-05-05 |
| Phase 3 | ||||
| NCT05174052 | Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF) | Diabetes Mellitus | Recruiting | 2026-04-01 |
| Phase 2/3 | ||||
| NCT06820034 | Empowering Cessation ACS South Region | Smoking Cessation | Recruiting | 2026-05-11 |
| NCT06821295 | Efficacy of a Smartphone-Based JITAI to Reduce Drinking Among Adults Experiencing… | Alcohol Misuse | Recruiting | 2026-05-01 |
| Phase 2 | ||||
| NCT07099638 | Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence… | Smoking Cessation | Recruiting | 2026-08-19 |
| NCT06296849 | Dyadic Financial Incentive Treatments for Dual Smoker Couples | Smoking, Cigarette | Recruiting | 2026-04-29 |
| NCT06488781 | Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae… | Obesity in Pregnancy | Recruiting | 2026-03-12 |
| NCT07223541 | Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell… | Clear Cell Renal Cell Carcinoma | Recruiting | 2026-03-02 |
| NCT07183319 | Circulating Tumor DNA Response In Urothelial Cancer | Urothelial Carcinoma | Recruiting | 2026-02-02 |
| NCT05512208 | A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib | Endometrioid Cancer | Recruiting | 2025-10-22 |
| NCT05617716 | Spine Radiosurgery for Symptomatic Metastatic Neoplasms | Metastatic Neoplasm to the Spine | Recruiting | 2025-10-20 |
| NCT05233228 | Mobile Health Technology for Personalized Tobacco Cessation Support in Laos | Cigarette Smoking | Recruiting | 2025-08-15 |
| NCT06516588 | tDCS for Post-Stroke Cognitive Impairment | Stroke | Recruiting | 2024-10-10 |
| NCT07861867 | AKG and Brain Health in Aging | Brain Aging | Not Yet Recruiting | 2026-10-06 |
| NCT06660017 | Head and Neck Cancer Patients With Oral Mucositis Treated With Ketamine Oral Rinse | Head and Neck Cancer | Not Yet Recruiting | 2026-08-18 |
| NCT03526432 | Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer | Endometrial Cancer | Active, Not Recruiting | 2026-07-30 |
| NCT07737795 | Evaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial Cancer | Endometrial Cancer | Not Yet Recruiting | 2026-07-30 |
| NCT07534332 | Disulfiram in Rheumatoid Arthritis | Rheumatoid Arthritis | Not Yet Recruiting | 2026-07-27 |
| NCT06129604 | Pilot Window of Opportunity Trial (POET) | Colorectal Carcinoma (CRC) | Active, Not Recruiting | 2026-07-15 |
| NCT06494150 | Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO) | Low Grade Ovarian Serous Adenocarcinoma | Active, Not Recruiting | 2026-06-12 |
Prostate Cancer (9) · Breast Cancer (5) · Colorectal Cancer (5) · Endometrial Cancer (4) · Head & Neck Cancer (4) · Lung Cancer (4) · Obesity (4) · Ovarian Cancer (4) · Pancreatic Cancer (4) · Bladder Cancer (3)